TKT and hepatocellular carcinoma: Finally, knockdown of transketolase (TKT) has been shown to result in a decrease in the levels of the antioxidant NADPH and an increase in ROS, and to remarkably reduce cell growth in two hepatocellular carcinoma cell lines and in vivo (Xu et al, 2016).